Role of Oxidant and Proinflammatory Cytokines and the Effect of Leflunomide in the Pathogenesis of Ovarian IschemiaReperfusion Injury
Özet
Background and Objective: Ischemia-reperfusion (IR) causes tissue damage by inducing oxidative stress and inflammation. In this study, the protective ability of leflunomide, which is reputed to have antioxidant and anti-inflammatory effects, against IR-induced ovarian damage in rats was researched. Materials and Methods: Twenty-four albino Wistar female rats were divided into 4 groups of six each: Healthy (HG), sham-operated (SOG),ovarian IR (OIR) and leflunomide+ovarian IR (LOIR).One hour beforethe IR procedure, the LOIRgroup received 10 mg/kg leflunomide orally. Ovaries of rats in OIR and LOIR groups were subjected to 3 hrs ischaemia and 6 hrs reperfusion. For six days, leflunomide were implemented once a day. On day seven, the animals were euthanized and their ovaries were collected. The tissues were examined biochemically and histopathologically. Results: Leflunomide treatment significantly suppressed IR-induced rise in malondialdehyde (MDA),Tumor Necrosis Factor-Alpha (TNF-) and Interleukin 6 (IL-6) and the decline in Total Glutathione (tGSH), superoxide dismutase (SOD) and catalase (CAT) (p<0.001). Severe stromal hemorrhage, edema and follicular hemorrhage were noted in the ovaries of the IR group. Leflunomide treatment significantly prevented IR-induced ovarian tissue damage (p<0.05). Conclusion: Leflunomide could protect the ovaries with antioxidant and anti-inflammatory activity in ovarian IR injury.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Isaoglu, Unal | |
| dc.contributor.author | Uyar, Elif Esra | |
| dc.contributor.author | Sahin, Nurullah | |
| dc.contributor.author | Bulut, Seval | |
| dc.contributor.author | Mammadov, Renad | |
| dc.contributor.author | Yilmaz, Betul Kalkan | |
| dc.contributor.author | Gunay, Murat | |
| dc.contributor.author | Mendil, Ali Sefa | |
| dc.contributor.author | Suleyman, Halis | |
| dc.date.accessioned | 2026-10-18T20:41:06.853109991Z | |
| dc.date.available | 2026-10-18T20:41:06.853109991Z | |
| dc.date.issued | 2024 | |
| dc.description.abstract | Background and Objective: Ischemia-reperfusion (IR) causes tissue damage by inducing oxidative stress and inflammation. In this study, the protective ability of leflunomide, which is reputed to have antioxidant and anti-inflammatory effects, against IR-induced ovarian damage in rats was researched. Materials and Methods: Twenty-four albino Wistar female rats were divided into 4 groups of six each: Healthy (HG), sham-operated (SOG),ovarian IR (OIR) and leflunomide+ovarian IR (LOIR).One hour beforethe IR procedure, the LOIRgroup received 10 mg/kg leflunomide orally. Ovaries of rats in OIR and LOIR groups were subjected to 3 hrs ischaemia and 6 hrs reperfusion. For six days, leflunomide were implemented once a day. On day seven, the animals were euthanized and their ovaries were collected. The tissues were examined biochemically and histopathologically. Results: Leflunomide treatment significantly suppressed IR-induced rise in malondialdehyde (MDA),Tumor Necrosis Factor-Alpha (TNF-) and Interleukin 6 (IL-6) and the decline in Total Glutathione (tGSH), superoxide dismutase (SOD) and catalase (CAT) (p<0.001). Severe stromal hemorrhage, edema and follicular hemorrhage were noted in the ovaries of the IR group. Leflunomide treatment significantly prevented IR-induced ovarian tissue damage (p<0.05). Conclusion: Leflunomide could protect the ovaries with antioxidant and anti-inflammatory activity in ovarian IR injury. | |
| dc.identifier.doi | 10.3923/ijp.2024.1440.1447 | |
| dc.identifier.eissn | 1812-5700 | |
| dc.identifier.issn | 1811-7775 | |
| dc.identifier.issue | 8 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/16884 | |
| dc.identifier.volume | 20 | |
| dc.identifier.wos | WOS:001406556100008 | |
| dc.language.iso | en | |
| dc.publisher | ASIAN NETWORK SCIENTIFIC INFORMATION-ANSINET | |
| dc.relation.ispartof | INTERNATIONAL JOURNAL OF PHARMACOLOGY | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Leflunomide | |
| dc.subject | ischemia-reperfusion | |
| dc.subject | oxidative stress | |
| dc.subject | inflammation | |
| dc.subject | ovarian damage | |
| dc.subject | rat | |
| dc.subject | ISCHEMIA-REPERFUSION INJURY | |
| dc.subject | ISCHEMIA/REPERFUSION INJURY | |
| dc.subject | Pharmacology & Pharmacy | |
| dc.title | Role of Oxidant and Proinflammatory Cytokines and the Effect of Leflunomide in the Pathogenesis of Ovarian IschemiaReperfusion Injury | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.wos | 0 | |
| rdl.oa.status | open | |
| rdl.source.index | WOS | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |
